Infinity Pharmaceuticals, Inc. (INFI) Social Stream



Infinity Pharmaceuticals, Inc. (INFI): $0.01

0.01 (-50.00%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add INFI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#67 of 404

in industry

INFINITY PHARMACEUTICALS INC (INFI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering INFINITY PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-10 7 $14 $4 $9.285 $0.045 20533.33%
2022-01-06 7 $14 $7 $9.714 $0.045 21486.67%
2022-01-21 7 $14 $5 $9.428 $0.045 20851.11%
2022-03-30 6 $14 $5 $9.428 $0.045 20851.11%
2022-03-31 7 $14 $4 $7.166 $0.045 15824.44%
2022-05-04 6 $14 $4 $6.8 $0.045 15011.11%
2022-05-23 4 $14 $3 $6.5 $0.045 14344.44%
2022-08-10 3 $4 $3 $3.333 $0.045 7306.67%
2022-11-14 2 $4 $3 $3.5 $0.045 7677.78%
2022-11-16 3 $4 $1.5 $2.833 $0.045 6195.56%
2023-02-23 1 $0.3 $0.3 $0.3 $0.045 566.67%

Price Target Last Issued February 23, 2023

The Trend in the Analyst Price Target


Over the past 24 months, INFI's average price target has gone down $5.45.

INFI reports an average of 347.67% for its upside potential over the past 101 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-14 3 4.0 3.0 3.50 0.740 372.97%
2022-11-14 2 4.0 3.0 3.50 0.740 372.97%
2023-02-23 1 0.3 0.3 0.30 0.281 6.76%
2023-02-23 2 0.3 0.3 0.30 0.281 6.76%
2023-02-23 2 4.0 0.3 2.15 0.281 665.12%

INFI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


INFI's average broker recommendation rating worsened by 2 over the prior 39 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how INFINITY PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1693.04% of that group.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, INFINITY PHARMACEUTICALS INC's average analyst price target is greater than 87.27% of them.
  • In terms of how INFINITY PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -1170.2% of that group.
  • INFINITY PHARMACEUTICALS INC's number of analysts covering the stock is higher than 359.75% of stocks in the mid market cap category.

Stocks similar to INFINITY PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are INSM, CORT, and INVA.

Make investment decisions regarding INFI using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!